Cargando…

Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview

Chronic obstructive pulmonary disease (COPD) is one of the major diseases threatening human life and health. According to the report released by the World Health Organization (WHO) in 2020, COPD has become the third leading cause of death in the world, featuring a sustainable growth of incidence rat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Liu-Ying, Zhang, Chuan-Tao, Zhu, Feng-Ya, Zheng, Gang, Liu, Yu-Fei, Liu, Ke, Zhang, Chen-Hui, Zhang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988065/ https://www.ncbi.nlm.nih.gov/pubmed/35401201 http://dx.doi.org/10.3389/fphar.2022.821941

Ejemplares similares

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

Imbalance of Endogenous Hydrogen Sulfide and Homocysteine in Chronic Obstructive Pulmonary Disease Combined with Cardiovascular Disease
por: He, Yanjing, et al.
Publicado: (2017)

Landscape analysis and overview of the literature on oxidative stress and pulmonary diseases
por: Liu, Xin, et al.
Publicado: (2023)

Analyze and Identify Peiminine Target EGFR Improve Lung Function and Alleviate Pulmonary Fibrosis to Prevent Exacerbation of Chronic Obstructive Pulmonary Disease by Phosphoproteomics Analysis
por: Ma, Xiaoyao, et al.
Publicado: (2019)

Editorial: Natural compounds regulating epigenetics for treating chronic inflammatory diseases
por: Zhang, Mingyu, et al.
Publicado: (2023)

Role of Proteases in Chronic Obstructive Pulmonary Disease
por: Pandey, Kailash C., et al.
Publicado: (2017)

Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease
por: Liu, Yanhui, et al.
Publicado: (2023)

Targeting pancreatic stellate cells in chronic pancreatitis: Focus on therapeutic drugs and natural compounds
por: Wu, Yang, et al.
Publicado: (2022)

Bioactive natural compounds as potential medications for osteogenic effects in a molecular docking approach
por: Wu, Yuqiong, et al.
Publicado: (2022)

The Efficacy and Safety of Revefenacin for the Treatment of Chronic Obstructive Pulmonary Disease: A Systematic Review
por: Zhang, Jiaxing, et al.
Publicado: (2021)

Bufei Jianpi Formula Improves Mitochondrial Function and Suppresses Mitophagy in Skeletal Muscle via the Adenosine Monophosphate-Activated Protein Kinase Pathway in Chronic Obstructive Pulmonary Disease
por: Mao, Jing, et al.
Publicado: (2020)

Monoclonal Antibodies Targeting IL-5 or IL-5Rα in Eosinophilic Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
por: Zhang, Chuchu, et al.
Publicado: (2021)

Unravelling the Therapeutic Potential of Botanicals Against Chronic Obstructive Pulmonary Disease (COPD): Molecular Insights and Future Perspectives
por: Mitra, Sicon, et al.
Publicado: (2022)

Efficacy and safety of three species of Rhodiola L. in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
por: Yu, Haichuan, et al.
Publicado: (2023)

Celastrol Alleviates Chronic Obstructive Pulmonary Disease by Inhibiting Cellular Inflammation Induced by Cigarette Smoke via the Ednrb/Kng1 Signaling Pathway
por: Shi, Ke, et al.
Publicado: (2018)

Real-world antibiotic use in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China: Evidence from the ACURE study
por: Ma, Yiming, et al.
Publicado: (2021)

Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome
por: Tang, Manyun, et al.
Publicado: (2021)

Pharmacological effects of Bufei Jianpi granule on chronic obstructive pulmonary disease and its metabolism in rats
por: Yang, Xin-Xin, et al.
Publicado: (2022)

Targeting Autophagy with Natural Compounds in Cancer: A Renewed Perspective from Molecular Mechanisms to Targeted Therapy
por: Xie, Qiang, et al.
Publicado: (2021)

The clinical characteristics and treatment response of patients with chronic obstructive pulmonary disease with low body mass index
por: Song, Qing, et al.
Publicado: (2023)

Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?
por: Liu, Meiling, et al.
Publicado: (2021)

Application of natural polysaccharides and their novel dosage forms in gynecological cancers: therapeutic implications from the diversity potential of natural compounds
por: Li, Yi, et al.
Publicado: (2023)

Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
por: Li, Shufen, et al.
Publicado: (2021)

Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Qibai Pingfei capsule on chronic obstructive pulmonary disease
por: Xie, Jinghui, et al.
Publicado: (2023)

Protective potential of hydroxysafflor yellow A in cerebral ischemia and reperfusion injury: An overview of evidence from experimental studies
por: Yu, Lu, et al.
Publicado: (2022)

Drug Safety of Benzodiazepines in Asian Patients With Chronic Obstructive Pulmonary Disease
por: Liao, Yi-Hsiang, et al.
Publicado: (2020)

Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Effect of pulmonary rehabilitation on heart rate recovery in adult individuals with asthma or chronic obstructive pulmonary disease
por: Zampogna, Elisabetta, et al.
Publicado: (2022)

Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
por: Duan, Linshan, et al.
Publicado: (2021)

Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials
por: Chen, Hong, et al.
Publicado: (2021)

SIRT1 Activation by Natural Phytochemicals: An Overview
por: Iside, Concetta, et al.
Publicado: (2020)

Methylxanthine Treatment in Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in China: A Real-World Study Using Propensity Score Matching Analysis
por: Zhan, Zijie, et al.
Publicado: (2022)

Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
por: Shen, Xuetong, et al.
Publicado: (2023)

Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms
por: Liu, Shiyu, et al.
Publicado: (2022)

Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease
por: Seshadri, Dhruv R., et al.
Publicado: (2018)

miR-4456/CCL3/CCR5 Pathway in the Pathogenesis of Tight Junction Impairment in Chronic Obstructive Pulmonary Disease
por: Yu, Weiwei, et al.
Publicado: (2021)

Herb-symptom analysis of Erchen decoction combined with Xiebai powder formula and its mechanism in the treatment of chronic obstructive pulmonary disease
por: Ye, Hua, et al.
Publicado: (2023)

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
por: Morales, Paula, et al.
Publicado: (2017)

Tai Chi for Chronic Obstructive Pulmonary Disease (COPD): An Overview of Systematic Reviews
por: Yang, Luping, et al.
Publicado: (2021)

Inhibiting Cytoprotective Autophagy in Cancer Therapy: An Update on Pharmacological Small-Molecule Compounds
por: Zhang, Lijuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kbd2686e39n8elfmdr3052414u